Toggle navigation
Home
About Us
Pipeline
Collaborations
Investors
Media Center
News Releases
Publications
Events
Careers
Contact Us
Site Map
Home
About Us
Pipeline
Collaborations
Investors
Media Center
News Releases
Publications
Events
Careers
Media Center
News Releases
Publications
Press Releases
Title Filter
Display #
5
10
15
20
25
30
50
100
All
Lexicon Pharmaceuticals Announces Dosing of First Patient in TELE-ABC Study, a Phase 2a Clinical Study of Telotristat Ethyl in Biliary Tract Cancer
Mar 15, 2019
Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides a Business Update
Mar 13, 2019
Lexicon Pharmaceuticals to Host Fourth Quarter and Full-Year 2018 Financial Results Conference Call and Webcast on March 13, 2019
Mar 11, 2019
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference
Mar 11, 2019
CHMP Recommends Zynquista™ (Sotagliflozin) for the Treatment of Adults with Type 1 Diabetes
Mar 01, 2019
Lexicon Pharmaceuticals Announces Poster Presentations at the 16th Annual ENETS Conference
Feb 28, 2019
FDA Advisory Committee Votes on Zynquista™ (Sotagliflozin) as Treatment for Adults with Type 1 Diabetes
Jan 17, 2019
Lexicon Pharmaceuticals to Host Conference Call and Webcast on January 17, 2019 to Discuss Outcome of FDA Advisory Committee Meeting for Sotagliflozin in Type 1 Diabetes
Jan 17, 2019
Lexicon Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Review Sotagliflozin New Drug Application for the Treatment of Type 1 Diabetes
Jan 17, 2019
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference
Dec 21, 2018
2
3
...
5
6
7
8
9
...
11
Copyright
©
2020, Lexicon Pharmaceuticals, Inc. All Rights Reserved
Privacy Policy
Terms of Use
Vendor Terms
Contact Us
Sitemap